BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Neuron
,
Laser capture microdissection
,
Ciprofibrate
,
rs2230926
,
FABP1
,
Influenza
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Schlafen family member 14
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
COVID-19
Sarcoidosis
Viral infections of the central nervous system
Myeloid leukemia
Amyotrophic lateral sclerosis
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
cyclocreatine
Hemin
Erythropoietin
phenylmethylpyrazolone
MCI 186
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
SPEN
SRSF1
LMO2
DLX3
ETV2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
OMIM - Blood coagulation disorders
Endothelial cells from embryos with hypomorphic and knockout allele combinations
Systemic Lupus Erythematosus trial of Tabalumab
Lymphoblastoid AH LCL and GM12878 cell lines treated with valproic acid or SAHA over a timecourse
Acute monocytic leukemia NB4 cells treated with specific FTO demethylase inhibitors FB23 and F23-2
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Schlafen family member 14
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Phase II Clinical Trial Evaluating the Combination of Olaparib and Temozolomide for the Treatment …
Testing Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive Biomarker
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ